Obstructive sleep apnoea/hypopnoea syndrome linked to NTG

Article

Moderate and severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is strongly linked to normal tension glaucoma (NTG).

Moderate and severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is strongly linked to normal tension glaucoma (NTG), claims a study in the Journal of Glaucoma.

Dr Pei-Wen Lin et al., Department of Ophthalmology, Kaohsiung Medical Center, Taiwan, conducted a polysomnographic exam on 256 participants to diagnose OSAHS. A complete ophthalmologic examination was performed on all participants. This included best-corrected visual acuity (BCVA), intraocular pressure, slit lamp biomicroscopy, gonioscopy, fundoscopy, automated visual field (VF) and retinal nerve fibre layer (RNFL) evaluation.

OSAHS was found in 209 patients out of the total examined and 38 were placed into the normal group. In the OSAHS group NTG was discovered in 12 patients. The prevalence was 5.7% - significantly higher than the normal group. Out of the NTG patients examined, one was found to have mild OSAHS, three were moderate and eight were severe.

Prevalence of NTG in moderate and severe OSAHS patients was 7.1%. This was significantly higher than normal and mild OSAHS patients. There were no incidences of glaucoma in the normal group.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.